In January, the British Association for Dermatologists warned about the growing trend of children using inappropriate ...

Regina Tan is the founder and CEO of Immortalize, a one-stop marketplace for elderhood and legacy planning needs. She shares ...

Singapore Today's Lance Alexander and Justine Moss speak with Dr Stephanie Ho, Dermatologist, Stephanie Ho Dermatology, about ...

Parents of children with eczema are more likely to be short on sleep and to use medication to try to get more of it, a ...

Luckily, there are options that specifically target eczema flare-ups and alleviate the symptoms, including shampoos that are ...

In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was ...

This latest approval is the second indication of the monoclonal antibody, Nemluvio. It was first approved in Aug. 2024 to ...

The approval was based on data from 2 randomized, double-blind, placebo-controlled trials, ARCADIA 1 and ARCADIA 2.

A monoclonal antibody that targets interleukin (IL)-31 receptor alpha, nemolizumab is specifically indicated for individuals ...

Switzerland’s Galderma has won US Food and Drug Administration (FDA) approval for the use of Nemluvio (nemolizumab) for ...

The US FDA has approved Galderma's Nemluvio (nemolizumab), for individuals aged 12 years and above with moderate-to-severe atopic dermatitis.

Kyle has had moderate to severe eczema across most of his body since he was an infant. Throughout his life, he’s faced a mix ...